FIELD: medicine.
SUBSTANCE: invention represents an oral anti-enteroviral and immunostimulant agent in the form of capsules containing interferon and additives, differing by the fact that a therapeutic substance is human recombinant interferon alpha-2b immobilised on polyethylene glycol, having a molecular weight of 1.5 kD by a physical method of binding by an accelerated electron flow in a dose of 1.5 Mrad. The ingredients in the agent are taken in a certain ratio.
EFFECT: extending the range of anti-enteroviral agents possessing immunostimulant properties.
6 ex, 10 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR BODY PROTECTION AGAINST INFECTION CAUSED BY INFLUENZA A VIRUS SUBTYPE H1N1 STRAINS WITH PREPARATION OF HUMAN ALPHA-2 INTERFERON | 2013 |
|
RU2523554C1 |
| AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
| METHOD OF TREATING GASTRIC AND/OR DUODENAL ULCER | 2013 |
|
RU2517789C1 |
| METHOD FOR TREATING ACUTE HEPRETIC STOMATITIS IN CHILDREN | 2011 |
|
RU2444372C1 |
| METHOD OF PREVENTING DISEASE CAUSED BY AVIAN FLU VIRUS | 2008 |
|
RU2395295C2 |
| METHOD OF INHIBITING INFECTIOUS ACTIVITY OF EBOLA VIRUS IN EXPERIMENT | 2015 |
|
RU2585695C1 |
| MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
| METHOD OF TREATING EXUDATIVE OTITIS MEDIA IN CHILDREN | 2010 |
|
RU2424821C1 |
| METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
| METHOD OF TREATMENT OF PATIENT WITH KAPOSI'S SARCOMA IDIOPATHIC TYPE | 1998 |
|
RU2140270C1 |
